The comparison of nasal irrigation outcome between 3% NaCl and 0.9% NaCl in adults majority with intermittent allergic rhinitis: A randomized double-blind study

被引:2
|
作者
Yata, Kedsaraporn [1 ]
Srivanitchapoom, Chonticha [1 ]
机构
[1] Phayao Hosp, Otolaryngol Unit, 269 Moo 11, Muang Phayao, Phayao, Thailand
关键词
nasal irrigation; 3% NaCl; 0.9% NaCl; hypertonic saline; allergic rhinitis; HYPERTONIC SALINE; MUCOCILIARY CLEARANCE; CHILDREN; ASTHMA; CONGESTION; IMPACT;
D O I
10.12932/AP-140520-0844
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Management of allergic rhinitis with oral antihistamine and steroid nasal spray are the standard treatment which is recommended by Allergic Rhinitis and its Impact on Asthma guidelines. In addition, nasal irrigation as an adjuvant therapy also provides a satisfactory result. Objective: To compare the treatment outcome in adults majority with intermittent allergic rhinitis who receive different concentrations of nasal irrigation. Methods: The prospective randomized double-blind study was performed in 80 patients. All patients were prescribed oral antihistamine and nasal irrigated solution between 3% NaCl and 0.9% NaCl. Nasal congestion and rhinorrhea were evaluated at baseline, first and second weeks after treatment. Assessments were measured by nasal congestion visual analog scale rhinorrhea visual analog scale, inferior turbinate size, and peak nasal expiratory flow rate (PNEFR). A p value of < 0.05 was considered statistically significant. Results: There were 40 patients in each group of the study. Patients reported satisfactory experience after using saline irrigation at first and second weeks in both solutions (p value < 0.001). However, when compared between groups, no significant differences for all parameters were reported. PNEFR showed good results after the first week of 3% NaCl irrigation (p value = 0.001), while 0.9% NaCl had good results after the second week (p value < 0.001). Conclusion: Both add-on treatments have a significant improvement of all 4 parameters assessed in the study: nasal congestion, rhinorrhca, inferior turbinate size and PNEFR. Of note, 3% NaCl but not 0.9 NaCl had improved the PNEFR earlier from 1 week of the treatment.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [21] Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study
    Yonekura, Syuji
    Okamoto, Yoshitaka
    Sakurai, Daiju
    Iinuma, Tomohisa
    Sakurai, Toshioki
    Yoneda, Riyo
    Kurita, Junya
    Hanazawa, Toyoyuki
    Kawasaki, Yohei
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 180 (04) : 274 - 283
  • [22] Evaluating the Impacts of Methylsulfonylmethane on Allergic Rhinitis After a Standard Allergen Challenge: Randomized Double-Blind Exploratory Study
    Hewlings, Susan
    Kalman, Douglas S.
    JMIR RESEARCH PROTOCOLS, 2018, 7 (11):
  • [23] A Nasally Applied Cellulose Powder in Seasonal Allergic Rhinitis in Adults with Grass Pollen Allergy: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study
    Aberg, Nils
    Ospanova, S. Tetjana
    Nikitin, Nikolai P.
    Emberlin, Jean
    Dahl, Aslog
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2014, 163 (04) : 313 - 318
  • [24] An ayurvedic approach to immunomodulation employing a green delivery of phytonutrients: A randomized, double-blind, placebo-controlled study on mild allergic rhinitis
    Mamatha, K.
    Aryan, Manu Kanjoormana
    Prabhakaran, Prathibha
    Das, S. Syam
    Panicker, Sreejith Parameswara
    JOURNAL OF FUNCTIONAL FOODS, 2024, 123
  • [25] Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial
    Moyad, Mark A.
    Robinson, Larry E.
    Kittelsrud, Julie M.
    Reeves, Stuart G.
    Weaver, Susan E.
    Guzman, Aireen I.
    Bubak, Mark E.
    ADVANCES IN THERAPY, 2009, 26 (08) : 795 - 804
  • [26] A randomized, double-blind placebo-controlled study of intranasal standardized cinnamon bark extract for seasonal allergic rhinitis
    Steels, Eleanor
    Steels, Elizabeth
    Deshpande, Pallavi
    Thakurdesai, Prasad
    Dighe, Satish
    Collet, Trudi
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 47
  • [27] Short-term influence of Immufen™ on mild allergic rhinitis: a randomized, double-blind, placebo-controlled study
    Mamatha, K.
    Aryan, Manu Kanjoormana
    Prabhakaran, Prathibha
    Mulakal, Johannah Natinga
    Das, S. Syam
    Krishnakumar, Im
    Panicker, Sreejith Parameswara
    FRONTIERS IN ALLERGY, 2024, 5
  • [28] Effect of Nebulized Beclomethasone on Airway Inflammation and Clinical Status of Children with Allergic Asthma and Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Study
    Profita, Mirella
    Riccobono, Loredana
    Bonanno, Anna
    Chanez, Pascal
    Gagliardo, Rosalia
    Montalbano, Angela Marina
    Albano, Giusy Daniela
    Liotta, Giuseppe
    Gjomarkaj, Mark
    La Grutta, Stefania
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2013, 161 (01) : 53 - 64
  • [29] A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
    Lukat, K. F.
    Rivas, P.
    Roger, A.
    Kowalski, M. L.
    Botzen, U.
    Wessel, F.
    Sanquer, F.
    Agache, I.
    Izquierdo, I.
    JOURNAL OF ASTHMA AND ALLERGY, 2013, 6 : 31 - 39
  • [30] Randomized double-blind pilot study of universal, species abundant, multiallergen subcutaneous immunotherapy for moderate-severe allergic rhinitis
    Tversky, Jody
    Patel, Pooja
    Sowho, Mudiaga
    Natarajan, Rakesh
    Chung, Tae
    Whelton, Andrew
    Azar, Antoine
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (01) : 89 - 95